Crowdstrike Holdings Inc vs Tempus AI — how do they compare? Crowdstrike Holdings Inc trades at $267.07 (market cap $269.31B), while Tempus AI trades at $72.29 (market cap $12.58B). The key difference: Crowdstrike Holdings Inc is far larger — about 21.4× Tempus AI's market cap, and Crowdstrike Holdings Inc is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Crowdstrike Holdings Inc for 97 Days and Tempus AI for 22 Days on average.
| CRWD | TEM | |
|---|---|---|
Market Cap | $269.31B | $12.58B |
Volume | 9,381,560 | 7,444,569 |
Sector | Technology | Broad Market / Factor |
52-Week High | $278.86 | $99.28 |
52-Week Low | $87.56 | $41.55 |
Typical Hold Time | 97 Days | 22 Days |
Enterprise Value | $265.11B | $13.21B |
Signals from Pluang's Aura AI — not financial advice
CrowdStrike (CRWD) trades at $265.44, down 4.81% on the day but remains near its 52-week high. The stock shows strong technical momentum with a bullish moving average signal and has consistently beaten earnings expectations in recent quarters. Revenue growth remains robust at $3.95 billion for 2025, though profitability metrics show mixed results with a net income margin of -0.49%. Analyst sentiment remains overwhelmingly positive with 76% buy ratings and a consensus price target of $235.74.
CrowdStrike presents a compelling growth story with strong revenue expansion and market leadership in cybersecurity, though elevated valuation multiples and recent profitability challenges warrant caution. The company benefits from AI-driven cybersecurity demand but faces execution risks and competitive pressures. Current levels offer potential for long-term investors comfortable with growth stock volatility.
Tempus AI (TEM) trades at $72.15, up 2.65% today, with a bullish technical signal and strong analyst support. The stock shows recent earnings beats but remains unprofitable, with a net income margin of -17.77% for 2026. Positive developments include FDA clearance for an AI product and expanded data partnerships, fueling investor optimism in the healthtech sector.
Outlook is cautiously optimistic given growth potential in AI-driven diagnostics, but high valuation (P/S 8.61) and persistent losses pose risks. Upside hinges on revenue scaling and path to profitability, with a consensus price target of $72.60 suggesting limited near-term gains from current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
CrowdStrike Holdings provides cybersecurity products and services aimed at protecting organizations from cyberthreats. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, identity protection, and log management. CrowdStrike went public in 2019 and serves customers worldwide.
Read more on CRWD →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →